SCHEMBL12123237

SCHEMBL12123237

Fc1ccc(-c2cc3cc4c(cc(-c5ccc(F)cc5)n4-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3n2-c2ccc(-n3c4ccccc4c4ccccc43)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ GRIA1 P42261 1/20 0.41
▸ CACNG8 Q8WXS5 1/20 0.41
▸ CACNG2 Q9Y698 1/20 0.41
▸ PTGS2 P35354 5/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ HAO1 Q9UJM8 1/20 0.37
▸ METAP2 P50579 1/20 0.37
▸ JAK2 O60674 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ HKDC1 Q2TB90 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ NR3C1 P04150 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12123253 0.92 KDM4E (0.45) KDM4EATML3MBTL1GRIA1CACNG8
SCHEMBL12123240 0.88 L3MBTL1 (0.52) KDM4EATML3MBTL1HAO1ALDH1A1
SCHEMBL12123233 0.88 L3MBTL1 (0.55) KDM4EATML3MBTL1HAO1ALDH1A1
SCHEMBL12345623 0.86 NR3C1 (0.48) GRIA1CACNG8CACNG2PTGS2HAO1
SCHEMBL12345624 0.86 HAO1 (0.44) GRIA1CACNG8CACNG2PTGS2HAO1
SCHEMBL12123384 0.86 KDM4E (0.39) KDM4EATML3MBTL1GRIA1CACNG8
SCHEMBL12123232 0.86 KDM4E (0.42) KDM4EATML3MBTL1RXFP1HAO1
SCHEMBL12123236 0.85 HTT (0.46) KDM4EATML3MBTL1NPSR1RXFP1
SCHEMBL12123355 0.85 KDM4E (0.38) KDM4EATML3MBTL1GRIA1CACNG8
SCHEMBL12123395 0.84 KDM4E (0.38) KDM4EATML3MBTL1GRIA1CACNG8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8057920-B2 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-11-15 — — US disclosed
US-8057920-B2 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-11-15 — — US disclosed
US-20090146555-A1 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-06-11 — — US disclosed
US-20090146555-A1 Heterocyclic compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090146555-A1 Heterocyclic compound and organic light emitting device comprising the same TRPC1, TRPC3, TRPC4 KDM4E 4097/4885ATM 3666/4885L3MBTL1 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback